Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ISRCTN10840798) titled 'Phase I Trial: Quotient Code QSC303299' on Feb. 6.
Study Type: Interventional
Study Design:
Allocation: N/A: single arm study
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: Phase I trial in healthy volunteers
Primary Sponsor: Vicore Pharma (Sweden)
Condition:
The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. Full details will be added to the study record within 30 months after the trial has ended.
Other
Intervention:
The sponsor has confirmed that the trial meets the criteria for deferral of publicati...